Sign In
Buy ANVS
$1.77
+0.0200 (+1.14%)
At Close: Jun 22, 2026
Kessler Topaz Meltzer & Check, LLP: Securities Fraud Class Action Lawsuit Filed Against Annovis Bio, Inc.
03:58pm, Friday, 27'th Aug 2021
RADNOR, Pa., Aug. 27, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed against Annovis Bio, Inc. (NYSE: AN
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Annovis Bio, Inc. - ANVS
03:45pm, Friday, 27'th Aug 2021
NEW YORK, Aug. 27, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Annovis Bio, Inc. ("Annovis" or the "Company") (NYSE: ANVS). Such investors are advised t
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ZY, ANVS and SESN
05:40am, Friday, 27'th Aug 2021
NEW YORK, NY / ACCESSWIRE / August 27, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to partic
New Orleans, Louisiana--(Newsfile Corp. - August 26, 2021) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with losses in
New York, New York--(Newsfile Corp. - August 26, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of
ANVS LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Annovis Bio, Inc.
03:21pm, Thursday, 26'th Aug 2021
New York, New York--(Newsfile Corp. - August 26, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased Annovis Bio, I
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Annovis Bio, Inc. (NYSE American: ANVS) between May 21, 2021 and July 28, 202
LOS ANGELES, Aug. 26, 2021 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Annovis Bio, Inc. ("Annovis" or "th
Better Biotech Stock: Cassava Sciences vs. Annovis Bio
05:49am, Thursday, 26'th Aug 2021
It boils down to which company's clinical trial results look better for treating Alzheimer's at the moment.
New York, New York--(Newsfile Corp. - August 26, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Annovis Bio, Inc. (NYSE: ANVS) alleging
ANVS NOTICE: Investors With Substantial Losses Have Opportunity to Lead the Annovis Bio, Inc. Class Action Lawsuit
08:00pm, Wednesday, 25'th Aug 2021
SAN DIEGO, Aug. 25, 2021 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers of Annovis Bio, Inc. (NYSE: ANVS) securities between May 21, 2021 and July 28, 2021, inclusive (the
New York, New York--(Newsfile Corp. - August 25, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of
New York, New York--(Newsfile Corp. - August 25, 2021) - The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders of Annovis Bio, Inc (NYSE Americ
NEW YORK--(BUSINESS WIRE)--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Annovis Bio, Inc. (“Annovis” or the “Company”) (NYSE: ANVS)
LOS ANGELES--(BUSINESS WIRE)---- $ANVS #ANVS--SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Annovis Bio, Inc.
